Digital Now what? The future of clinical trials after the pandemic Sheila Rocchio highlights four key areas life sciences must improve on as an industry to drive real change in how clinical trials are conducted.
Partner Content Partner Content COUCH Health Finds Reasons Behind Underrepresentation of Min... New research shows how to improve trial diversity
Partner Content Partner Content Formedix Expedites Clinical Trial Build with New Cloud Clini... New cloud clinical MDR to expedite trial design & build
White Papers Sponsored A digital health roadmap for pharma, medical devices and ins... COVID-19 has massively accelerated the uptake of digital health technology across the whole ecosystem, with important implications for pharma, medical device and insurance tech companies.
Events Partner Content World Orphan Drug Congress USA Virtual 2021 World Orphan Drug Congress USA Virtual
Views & Analysis The power of communication: engaging diverse groups in healt... Humans are diverse and communications to engage us need to be inclusive.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.